Navigation Links
The Merinoff Symposia to Highlight New Research in Systemic Lupus
Date:9/24/2008

The Feinstein Institute for Medical Research is hosting a three-day meeting for scientists interested in learning about the latest scientific studies underway in understanding and treating Systemic Lupus.

Manhasset, NY (PRWEB) September 24, 2008 -- The Feinstein Institute for Medical Research is hosting a three-day meeting for scientists interested in learning about the latest scientific studies underway in understanding and treating Systemic Lupus. Feinstein scientists are known worldwide for their contributions to the field of immunology, and in particular lupus and other autoimmune diseases, and have organized a novel meeting to share the science with immunologists on the front lines of taking care of patients. This is the first international Merinoff Symposia, which will become an annual event hosted by The Feinstein Institute. The conference was organized by Betty Diamond, MD, head of the Center for Autoimmune and Musculoskeletal Disorders at The Feinstein; Peter K. Gregersen, MD, head of the Boas Center for Genomics and Human Genetics at The Feinstein; and Timothy Behrens, MD, senior director of ITGR Exploratory Clinical Development at Genentech.

Michael Nussenzweig, MD, PhD, will deliver the opening lecture on “Antibody Tolerance in Humans.” The meeting is designed to enable doctors and scientists to understand how the immune system works to protect against disease and how a faulty immune response can set the stage for disease. Understanding lupus is a window into how the immune system fails to protect itself. Lupus is an autoimmune disease that can target many body systems, including the brain, and cause a host of different and disabling symptoms. Scientists will speak about innate and adaptive immunity, and how B-cells and T-cells of the immune system are activated in lupus and ways that scientists are intervening to stop or slow this autoimmune disease. There will be talks on human disease and tissue responses; and genes and gene expression in autoimmune diseases.

Several Feinstein scientists will share their research. Dr. Diamond, a member of the Institute of Medicine of the National Academies, has spent decades unraveling the puzzle of lupus. Her most recent work centers on how the brain receives signals from the faulty immune system, and how this process triggers a number of psychiatric and cognitive problems. Kevin J. Tracey, MD, director and chief executive officer of The Feinstein Institute, will talk about his studies of the “Inflammatory reflex: Neural regulation of the immune system.” His work has shown how the brain speaks directly to the immune system and why this is critical in figuring out how autoimmune and pro-inflammatory conditions arise. Invited speakers come from all over the world and are experts in lupus and autoimmunity.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1380364.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Keynoters, symposia, workshops highlight dental research meeting
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. Highlights of Economic and Business Growth in the Tampa Bay Region
4. Model highlights benefits and risks of cervical cancer screening methods
5. Registered Nurses at UW Medical Center Hold Candlelight Vigil to Highlight Concerns for Quality and Safe Patient Care
6. Session highlights of the 1st World Congress on Interventional Therapies for Type 2 Diabetes
7. Dental Convention to Highlight Latest Breakthroughs in Dentistry
8. September 2008 Mayo Clinic Womens HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol
9. September Ophthalmology research highlights
10. AHIP: Uninsured Report Highlights Urgent Social and Economic Challenge for the Nation
11. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Merinoff Symposia to Highlight New Research in Systemic Lupus
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really works. ... be incorporated into the post-surgical treatment plans of a variety of other procedures including, ... is very effective for bruising and causes a rapid resolution of bruising and inflammatory ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and University ... Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate of ... she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: